You are here: All Products  > Everest Medicines Starts China Trial of Triple-Negative Breast Cancer ADC

Everest Medicines Starts China Trial of Triple-Negative Breast Cancer ADC

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products